48,830
edits
(→Biopsy) |
|||
Line 8: | Line 8: | ||
| LMDDx = [[chromophobe renal cell carcinoma]] eosinophilic variant, [[clear cell renal cell carcinoma]] eosinophilic variant, [[papillary renal cell carcinoma]] oncocytic variant | | LMDDx = [[chromophobe renal cell carcinoma]] eosinophilic variant, [[clear cell renal cell carcinoma]] eosinophilic variant, [[papillary renal cell carcinoma]] oncocytic variant | ||
| Stains = [[Hale's colloidal iron]] -ve | | Stains = [[Hale's colloidal iron]] -ve | ||
| IHC = CK7 -ve/cytoplasmic +ve | | IHC = CK7 -ve/cytoplasmic +ve, PAX2 +ve | ||
| EM = abundant mitochondria | | EM = abundant mitochondria | ||
| Molecular = | | Molecular = | ||
Line 17: | Line 17: | ||
| Assdx = | | Assdx = | ||
| Syndromes = | | Syndromes = | ||
| Clinicalhx = | | Clinicalhx = often incidentally discovered mass | ||
| Signs = | | Signs = | ||
| Symptoms = | | Symptoms = | ||
| Prevalence = | | Prevalence = | ||
| Bloodwork = | | Bloodwork = | ||
| Rads = central scar | | Rads = renal mass with central scar (classic) | ||
| Endoscopy = | | Endoscopy = | ||
| Prognosis = benign | | Prognosis = benign | ||
Line 74: | Line 74: | ||
**[[Chromophobe renal cell carcinoma]] = cell membrane +ve. | **[[Chromophobe renal cell carcinoma]] = cell membrane +ve. | ||
*PAX2 +ve .<ref name=pmid17210525>{{cite journal |author=Memeo L, Jhang J, Assaad AM, ''et al.'' |title=Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: value in the differential diagnosis of chromophobe cell carcinoma |journal=Am. J. Clin. Pathol. |volume=127 |issue=2 |pages=225–9 |year=2007 |month=February |pmid=17210525 |doi=10.1309/9KWEA4W9Y94D1AEE |url=http://ajcp.ascpjournals.org/cgi/pmidlookup?view=long&pmid=17210525}}</ref> | *PAX2 +ve.<ref name=pmid17210525>{{cite journal |author=Memeo L, Jhang J, Assaad AM, ''et al.'' |title=Immunohistochemical analysis for cytokeratin 7, KIT, and PAX2: value in the differential diagnosis of chromophobe cell carcinoma |journal=Am. J. Clin. Pathol. |volume=127 |issue=2 |pages=225–9 |year=2007 |month=February |pmid=17210525 |doi=10.1309/9KWEA4W9Y94D1AEE |url=http://ajcp.ascpjournals.org/cgi/pmidlookup?view=long&pmid=17210525}}</ref> | ||
**Oncocytoma 20 of 23 +ve versus ChRCC 1 of 11 +ve. | **Oncocytoma 20 of 23 +ve versus ChRCC 1 of 11 +ve. | ||
edits